427 related articles for article (PubMed ID: 31549952)
21. First report of sporadic cases of Candida auris in Colombia.
Parra-Giraldo CM; Valderrama SL; Cortes-Fraile G; Garzón JR; Ariza BE; Morio F; Linares-Linares MY; Ceballos-Garzón A; de la Hoz A; Hernandez C; Alvarez-Moreno C; Le Pape P
Int J Infect Dis; 2018 Apr; 69():63-67. PubMed ID: 29421668
[TBL] [Abstract][Full Text] [Related]
22. Pan-resistant Candida auris isolates from the outbreak in New York are susceptible to ibrexafungerp (a glucan synthase inhibitor).
Zhu YC; Barat SA; Borroto-Esoda K; Angulo D; Chaturvedi S; Chaturvedi V
Int J Antimicrob Agents; 2020 Apr; 55(4):105922. PubMed ID: 32092395
[No Abstract] [Full Text] [Related]
23. Relative Resistance of the Emerging Fungal Pathogen Candida auris and Other Candida Species to Killing by Ultraviolet Light.
Cadnum JL; Shaikh AA; Piedrahita CT; Jencson AL; Larkin EL; Ghannoum MA; Donskey CJ
Infect Control Hosp Epidemiol; 2018 Jan; 39(1):94-96. PubMed ID: 29157326
[TBL] [Abstract][Full Text] [Related]
24. Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel.
Ben-Ami R; Berman J; Novikov A; Bash E; Shachor-Meyouhas Y; Zakin S; Maor Y; Tarabia J; Schechner V; Adler A; Finn T
Emerg Infect Dis; 2017 Feb; 23(1):195-203. PubMed ID: 28098529
[TBL] [Abstract][Full Text] [Related]
25. Candida auris: An emerging drug resistant yeast - A mini-review.
Bidaud AL; Chowdhary A; Dannaoui E
J Mycol Med; 2018 Sep; 28(3):568-573. PubMed ID: 30030072
[TBL] [Abstract][Full Text] [Related]
26. Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016-2017
van Schalkwyk E; Mpembe RS; Thomas J; Shuping L; Ismail H; Lowman W; Karstaedt AS; Chibabhai V; Wadula J; Avenant T; Messina A; Govind CN; Moodley K; Dawood H; Ramjathan P; Govender NP;
Emerg Infect Dis; 2019 Sep; 25(9):1698-1707. PubMed ID: 31441749
[TBL] [Abstract][Full Text] [Related]
27. A rare fungus on the rise:
Lee Y; Bao H; Viramgama S
Am J Health Syst Pharm; 2018 Jul; 75(14):1013-1017. PubMed ID: 29895519
[TBL] [Abstract][Full Text] [Related]
28. The Candida auris Alert: Facts and Perspectives.
Lamoth F; Kontoyiannis DP
J Infect Dis; 2018 Jan; 217(4):516-520. PubMed ID: 29390110
[No Abstract] [Full Text] [Related]
29. Management of Patients with Candida auris Fungemia at Community Hospital, Brooklyn, New York, USA, 2016-2018
Park JY; Bradley N; Brooks S; Burney S; Wassner C
Emerg Infect Dis; 2019 Mar; 25(3):601-602. PubMed ID: 30789336
[TBL] [Abstract][Full Text] [Related]
30. Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia.
Morales-López SE; Parra-Giraldo CM; Ceballos-Garzón A; Martínez HP; Rodríguez GJ; Álvarez-Moreno CA; Rodríguez JY
Emerg Infect Dis; 2017 Jan; 23(1):162-164. PubMed ID: 27983941
[TBL] [Abstract][Full Text] [Related]
31. Candida auris: Epidemiology, biology, antifungal resistance, and virulence.
Du H; Bing J; Hu T; Ennis CL; Nobile CJ; Huang G
PLoS Pathog; 2020 Oct; 16(10):e1008921. PubMed ID: 33091071
[TBL] [Abstract][Full Text] [Related]
32. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species.
Muñoz JF; Gade L; Chow NA; Loparev VN; Juieng P; Berkow EL; Farrer RA; Litvintseva AP; Cuomo CA
Nat Commun; 2018 Dec; 9(1):5346. PubMed ID: 30559369
[TBL] [Abstract][Full Text] [Related]
33. Containment strategies to address the expanding threat of multidrug-resistant Candida auris.
McCarthy MW; Walsh TJ
Expert Rev Anti Infect Ther; 2017 Dec; 15(12):1095-1099. PubMed ID: 29110544
[TBL] [Abstract][Full Text] [Related]
34. The laboratory investigation, management, and infection prevention and control of
Jones CR; Neill C; Borman AM; Budd EL; Cummins M; Fry C; Guy RL; Jeffery K; Johnson EM; Manuel R; Mirfenderesky M; Moore G; Patel B; Schelenz S; Staniforth K; Taori SK; Brown CS
J Med Microbiol; 2024 May; 73(5):. PubMed ID: 38771623
[TBL] [Abstract][Full Text] [Related]
35. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
[No Abstract] [Full Text] [Related]
36. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
[No Abstract] [Full Text] [Related]
37. [Candida auris: The Recent Emergence of a Multiresistant Pathogenic Fungi].
Antunes F; Veríssimo C; Pereira ÁA; Sabino R
Acta Med Port; 2020 Oct; 33(10):680-684. PubMed ID: 33135623
[TBL] [Abstract][Full Text] [Related]
38. Methods for identification of Candida auris, the yeast of global public health concern: A review.
Mahmoudi S; Agha Kuchak Afshari S; Aghaei Gharehbolagh S; Mirhendi H; Makimura K
J Mycol Med; 2019 Jun; 29(2):174-179. PubMed ID: 31031132
[TBL] [Abstract][Full Text] [Related]
39. Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains.
Iguchi S; Itakura Y; Yoshida A; Kamada K; Mizushima R; Arai Y; Uzawa Y; Kikuchi K
J Infect Chemother; 2019 Oct; 25(10):743-749. PubMed ID: 31257156
[TBL] [Abstract][Full Text] [Related]
40.
Kohlenberg A; Struelens MJ; Monnet DL; Plachouras D;
Euro Surveill; 2018 Mar; 23(13):. PubMed ID: 29616608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
